Teleflex Incorporated Common Stock (NY:TFX)

Over the last six months, Teleflex’s shares have sunk to $111.34, producing a disappointing 12.2% loss - a stark contrast to the S&P 500’s 16.4% gain. This may have investors wondering how to approach...

3 Reasons to Sell TFX and 1 Stock to Buy Instead

November 12, 2025

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

Topics Stocks

3 Unprofitable Stocks That Concern Us

November 11, 2025

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Shares of medical technology company Teleflex (NYSE:TFX) fell 15.5% in the morning session after the company reported underwhelming earnings. The medical technology firm's operating margin collapsed to...

Topics Artificial Intelligence Stocks

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

These Analysts Cut Their Forecasts On Teleflex Following Q3 Results ↗

November 07, 2025

Via Benzinga

Why Teleflex (TFX) Stock Is Falling Today

November 06, 2025

Teleflex (NYSE:TFX) Q3 Earnings Beat Estimates Amid Impairment Charges and Mixed Outlook ↗

Topics Artificial Intelligence Economy Government

November 06, 2025

Teleflex posted strong Q3 revenue and beat EPS estimates, but faces headwinds from impairment charges and a mixed full-year outlook.

Via Chartmill

Topics Earnings

Teleflex’s (NYSE:TFX) Q3 Sales Top Estimates

November 06, 2025

Medical technology company Teleflex (NYSE:TFX) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 19.4% year on year to $913 million. Its non-GAAP profit of $3.67 per...

Teleflex Announces Quarterly Dividend

November 06, 2025

Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

November 06, 2025

Medical technology company Teleflex (NYSE:TFX) will be reporting results this Thursday morning. Here’s what to look for.

Teleflex (TFX) Q3 Earnings: What To Expect

November 04, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

1 Safe-and-Steady Stock Worth Investigating and 2 Facing Challenges

November 02, 2025

Discover Teleflex Inc (TFX), an undervalued stock with strong financials, solid profitability, and a low P/E ratio, offering a potential margin of safety for value investors.

Teleflex Inc (NYSE:TFX) Presents a Compelling Case for Value Investors ↗

October 22, 2025

Via Chartmill

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

October 16, 2025

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Shares of medical technology company Teleflex (NYSE:TFX) fell 5.4% in the afternoon session after the U.S. government launched a probe into the medical device industry.

Topics Economy Government World Trade

Why Teleflex (TFX) Stock Is Trading Lower Today

September 25, 2025

Teleflex Inc (NYSE:TFX) Screened as a Potential Value Investment with Strong Fundamentals ↗

Topics Artificial Intelligence

September 23, 2025

Teleflex Inc (TFX) appears undervalued with a low P/E ratio, strong profitability, solid financial health, and positive growth forecasts, making it a compelling stock for value investors.

Via Chartmill

A Look Back at Surgical Equipment & Consumables - Specialty Stocks’ Q2 Earnings: Teleflex (NYSE:TFX) Vs The Rest Of The Pack

September 18, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables -...

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

Topics Artificial Intelligence Economy

September 11, 2025

The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

1 Safe-and-Steady Stock on Our Buy List and 2 We Find Risky

September 11, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

3 Cash-Producing Stocks Walking a Fine Line

September 08, 2025

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

August 26, 2025

Discover Teleflex Inc. (TFX), an undervalued medical tech stock with strong fundamentals, solid profitability, and a compelling valuation for value investors.

Teleflex Inc. (NYSE:TFX) Emerges as a Top Value Stock with Strong Fundamentals ↗

August 25, 2025

Via Chartmill

1 Healthcare Stock Worth Investigating and 2 Facing Challenges

August 20, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Insiders are buying stocks like LLY, TFX, and CALC. The question is whether they are also a good buy for investors, and not all of them are.

Topics Stocks

Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare Stocks ↗

August 19, 2025

Via MarketBeat

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy

August 19, 2025

Medical technology company Teleflex (NYSE:TFX) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 2.3% year on year to $780.9 million. Its non-GAAP profit of $3.73 per share was 10.8%...

TFX Q2 Deep Dive: Interventional Growth and Strategic Portfolio Shifts Define Outlook

August 12, 2025

Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know

Topics World Trade

August 12, 2025

A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed...

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Topics Bonds Economy Stocks

3 Value Stocks with Questionable Fundamentals

August 11, 2025